It is concluded that natural polysaccharides are promising, low-toxicity therapeutic agents for AD management, but for complete validation of their therapeutic potential, standardized pharmacokinetic profiling, rigorous safety assessment, and well-designed clinical trials are urgently required.
Noor Muhammad, Rui Ai, Li-Min Yang et al.· Frontiers in Aging Neuroscie...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.